Tags

Type your tag names separated by a space and hit enter

Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin.
Eur J Clin Nutr. 2006 Jun; 60(6):802-9.EJ

Abstract

BACKGROUND

Patients with metabolic syndrome (MS) have above-average risk of developing atherosclerosis and cardiovascular disease. Inflammation plays a key role in the development of atherosclerosis. High levels of the acute phase reactants C-reactive protein (CRP) and ferritin have been reported to correlate with various components of MS.

PATIENTS AND METHODS

The serum CRP, ferritin, glucose, insulin, triglycerides, HDL-cholesterol and total cholesterol concentrations of 598 obese or overweight patients were determined, together with relevant anthropometric parameters. Insulin resistance was evaluated by the HOMA method. MS was diagnosed using the ATP III criteria.

RESULTS

CRP levels were higher among patients with central obesity than in those without (5.8 vs 3.9 mg/l; P=0.003), and higher among those with fasting plasma glucose concentrations >or=110 mg/dl than in those with lower concentrations (7.4 vs 4.1 mg/l; P=0.01). Serum ferritin levels were higher among patients with triglyceride concentrations >or=150 mg/dl than in those with lower levels (76.8 vs 40.1 ng/ml; P<0.001), and higher among those with fasting plasma glucose concentrations >or=110 mg/dl than in those with lower concentrations (75.7 vs 41.7 ng/ml; P=0.005). The number of MS criteria that were satisfied increased with CRP and ferritin levels. Patients with insulin resistance also had higher CRP and ferritin levels than those without, 7.3 vs 4.3 mg/l for CRP (P=0.032) and 124.5 vs 80.1 ng/ml for ferritin (P<0.001).

CONCLUSIONS

MS and insulin resistance are associated with elevated serum CRP and ferritin. Evaluation of subclinical chronic inflammation in patients with MS and/or insulin resistance by determination of these markers might aid in their evaluation as candidates for aggressive intervention against cardiovascular risk factors.

Authors+Show Affiliations

Endocrinology and Nutrition Service, Juan Canalejo Hospital, La Coruña, Spain. Asoto@canalejo.orgNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

16493453

Citation

González, A Soto, et al. "Metabolic Syndrome, Insulin Resistance and the Inflammation Markers C-reactive Protein and Ferritin." European Journal of Clinical Nutrition, vol. 60, no. 6, 2006, pp. 802-9.
González AS, Guerrero DB, Soto MB, et al. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin. Eur J Clin Nutr. 2006;60(6):802-9.
González, A. S., Guerrero, D. B., Soto, M. B., Díaz, S. P., Martinez-Olmos, M., & Vidal, O. (2006). Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin. European Journal of Clinical Nutrition, 60(6), 802-9.
González AS, et al. Metabolic Syndrome, Insulin Resistance and the Inflammation Markers C-reactive Protein and Ferritin. Eur J Clin Nutr. 2006;60(6):802-9. PubMed PMID: 16493453.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin. AU - González,A Soto, AU - Guerrero,D Bellido, AU - Soto,M Buño, AU - Díaz,S Pértega, AU - Martinez-Olmos,M, AU - Vidal,O, Y1 - 2006/02/22/ PY - 2006/2/24/pubmed PY - 2006/10/25/medline PY - 2006/2/24/entrez SP - 802 EP - 9 JF - European journal of clinical nutrition JO - Eur J Clin Nutr VL - 60 IS - 6 N2 - BACKGROUND: Patients with metabolic syndrome (MS) have above-average risk of developing atherosclerosis and cardiovascular disease. Inflammation plays a key role in the development of atherosclerosis. High levels of the acute phase reactants C-reactive protein (CRP) and ferritin have been reported to correlate with various components of MS. PATIENTS AND METHODS: The serum CRP, ferritin, glucose, insulin, triglycerides, HDL-cholesterol and total cholesterol concentrations of 598 obese or overweight patients were determined, together with relevant anthropometric parameters. Insulin resistance was evaluated by the HOMA method. MS was diagnosed using the ATP III criteria. RESULTS: CRP levels were higher among patients with central obesity than in those without (5.8 vs 3.9 mg/l; P=0.003), and higher among those with fasting plasma glucose concentrations >or=110 mg/dl than in those with lower concentrations (7.4 vs 4.1 mg/l; P=0.01). Serum ferritin levels were higher among patients with triglyceride concentrations >or=150 mg/dl than in those with lower levels (76.8 vs 40.1 ng/ml; P<0.001), and higher among those with fasting plasma glucose concentrations >or=110 mg/dl than in those with lower concentrations (75.7 vs 41.7 ng/ml; P=0.005). The number of MS criteria that were satisfied increased with CRP and ferritin levels. Patients with insulin resistance also had higher CRP and ferritin levels than those without, 7.3 vs 4.3 mg/l for CRP (P=0.032) and 124.5 vs 80.1 ng/ml for ferritin (P<0.001). CONCLUSIONS: MS and insulin resistance are associated with elevated serum CRP and ferritin. Evaluation of subclinical chronic inflammation in patients with MS and/or insulin resistance by determination of these markers might aid in their evaluation as candidates for aggressive intervention against cardiovascular risk factors. SN - 0954-3007 UR - https://www.unboundmedicine.com/medline/citation/16493453/Metabolic_syndrome_insulin_resistance_and_the_inflammation_markers_C_reactive_protein_and_ferritin_ L2 - https://doi.org/10.1038/sj.ejcn.1602384 DB - PRIME DP - Unbound Medicine ER -